These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29785777)
21. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567 [TBL] [Abstract][Full Text] [Related]
22. Fragile X syndrome: From protein function to therapy. Bagni C; Oostra BA Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651 [TBL] [Abstract][Full Text] [Related]
23. Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome. Pacey LK; Tharmalingam S; Hampson DR J Pharmacol Exp Ther; 2011 Sep; 338(3):897-905. PubMed ID: 21636656 [TBL] [Abstract][Full Text] [Related]
24. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades. Gao MM; Shi H; Yan HJ; Long YS J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274 [TBL] [Abstract][Full Text] [Related]
25. GABAB receptor upregulates fragile X mental retardation protein expression in neurons. Zhang W; Xu C; Tu H; Wang Y; Sun Q; Hu P; Hu Y; Rondard P; Liu J Sci Rep; 2015 May; 5():10468. PubMed ID: 26020477 [TBL] [Abstract][Full Text] [Related]
26. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome. Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260 [TBL] [Abstract][Full Text] [Related]
27. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9. Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818 [TBL] [Abstract][Full Text] [Related]
28. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Olmos-Serrano JL; Corbin JG; Burns MP Dev Neurosci; 2011; 33(5):395-403. PubMed ID: 22067669 [TBL] [Abstract][Full Text] [Related]
29. The activation of mGluR4 rescues parallel fiber synaptic transmission and LTP, motor learning and social behavior in a mouse model of Fragile X Syndrome. Martín R; Suárez-Pinilla AS; García-Font N; Laguna-Luque ML; López-Ramos JC; Oset-Gasque MJ; Gruart A; Delgado-García JM; Torres M; Sánchez-Prieto J Mol Autism; 2023 Apr; 14(1):14. PubMed ID: 37029391 [TBL] [Abstract][Full Text] [Related]
30. Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome. Padmashri R; Reiner BC; Suresh A; Spartz E; Dunaevsky A J Neurosci; 2013 Dec; 33(50):19715-23. PubMed ID: 24336735 [TBL] [Abstract][Full Text] [Related]
31. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome. Wahlstrom-Helgren S; Klyachko VA J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581 [TBL] [Abstract][Full Text] [Related]
32. Development of GABAergic Inputs Is Not Altered in Early Maturation of Adult Born Dentate Granule Neurons in Fragile X Mice. Remmers CL; Contractor A eNeuro; 2018; 5(6):. PubMed ID: 30627633 [TBL] [Abstract][Full Text] [Related]
33. microRNAs and Fragile X Syndrome. Lin SL Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181 [TBL] [Abstract][Full Text] [Related]
34. Enhanced Excitatory Connectivity and Disturbed Sound Processing in the Auditory Brainstem of Fragile X Mice. Garcia-Pino E; Gessele N; Koch U J Neurosci; 2017 Aug; 37(31):7403-7419. PubMed ID: 28674175 [TBL] [Abstract][Full Text] [Related]
35. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948 [TBL] [Abstract][Full Text] [Related]
36. BDNF in fragile X syndrome. Castrén ML; Castrén E Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436 [TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome. Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918 [TBL] [Abstract][Full Text] [Related]
38. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome. Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451 [TBL] [Abstract][Full Text] [Related]
39. Role of FMRP in AKT/mTOR pathway-mediated hippocampal autophagy in fragile X syndrome. Zhang B; Zhang J; Chen H; Qiao D; Guo F; Hu X; Qin C; Jin X; Zhang K; Wang C; Cui H; Li S Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111036. PubMed ID: 38823765 [TBL] [Abstract][Full Text] [Related]
40. Chronic minocycline treatment improves social recognition memory in adult male Fmr1 knockout mice. Yau SY; Chiu C; Vetrici M; Christie BR Behav Brain Res; 2016 Oct; 312():77-83. PubMed ID: 27291517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]